NIAID Investigating New Treatment for Hepatitis C in Co-Infected Patients
Posted on Sunday, September 27th, 2009 at 11:00 AMThe Centers for Disease Control and Prevention estimates that approximately 25 percent of HIV-infected people in the United States are also infected with the hepatitis C virus (HCV).
HCV infection is a major cause of liver damage and progresses more rapidly in HIV-infected people. Researchers at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), are enrolling volunteers for a clinical trial to evaluate a new treatment that may suppress the HCV virus in HIV/HCV co-infected patients.
The clinical trial is being conducted at the NIH in Bethesda, MD.
For more information – HIV Information – Talk About HIV – HEP Information – Talk About HEP
NIAID News gave me permission to share this information with you. I want all of my readers to know what is going on with HIV. Thanks so much for reading my blog.







Dr.Harry W. Diehl was the discoverer of Cetyl Myristoleate. Best known for his Award winning research of CM8 and its great effectiveness in the treatment of osteo-arthritis symptoms.
Please stop spamming my blog.